ECS Botanics Holdings Ltd
ASX:ECS Stock Report
ECS Botanics Holdings Balance Sheet Health
Financial Health criteria checks 6/6 ECS Botanics Holdings has a total shareholder equity of A$28.2M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$32.9M and A$4.7M respectively. ECS Botanics Holdings's EBIT is A$1.9M making its interest coverage ratio 70.8. It has cash and short-term investments of A$3.2M.
Key information Interest coverage ratio 70.8x Cash AU$3.16m Equity AU$28.21m Total liabilities AU$4.67m Total assets AU$32.88m
Recent financial health updates
Show all updates
Lacklustre Performance Is Driving ECS Botanics Holdings Ltd's (ASX:ECS) 26% Price Drop Nov 11
ECS Botanics Holdings Ltd, Annual General Meeting, Nov 21, 2024 Oct 03
There's No Escaping ECS Botanics Holdings Ltd's (ASX:ECS) Muted Earnings Despite A 38% Share Price Rise Sep 27
ECS Botanics Holdings Ltd Announces Management Appointments Sep 20
Full year 2024 earnings released: EPS: AU$0.002 (vs AU$0 in FY 2023) Aug 29
New minor risk - Share price stability Aug 28
ECS Botanics Holdings Ltd's (ASX:ECS) Shares Lagging The Market But So Is The Business Aug 12
There Is A Reason ECS Botanics Holdings Ltd's (ASX:ECS) Price Is Undemanding Apr 03
New minor risk - Profit margin trend Mar 06
New minor risk - Shareholder dilution Mar 01
First half 2024 earnings released: EPS: AU$0.001 (vs AU$0.001 loss in 1H 2023) Feb 29 ECS Botanics Holdings Ltd to Report Q2, 2024 Results on Feb 28, 2024 Feb 26
ECS Botanics Holdings Ltd has completed a Follow-on Equity Offering in the amount of AUD 4.000016 million. Feb 23
ECS Botanics Holdings Ltd's (ASX:ECS) Share Price Could Signal Some Risk Sep 06
Full year 2023 earnings released: EPS: AU$0 (vs AU$0.001 loss in FY 2022) Sep 01
New minor risk - Financial data availability Aug 30
ECS Botanics Holdings Ltd, Annual General Meeting, Oct 26, 2023 Aug 25
ECS Botanics Holdings Ltd Launches Investor Hub Jun 14
First half 2023 earnings released: AU$0.001 loss per share (vs AU$0.003 loss in 1H 2022) Mar 03
ECS Botanics Holdings Ltd Announces Resignation of Mr. Alex Keach as Head of Corporate Development and an Executive Director Feb 10
No independent directors Nov 16
Blue Buffalo Pty Ltd has entered into a binding share purchase agreement to acquire ECS Botanics Pty Ltd from ECS Botanics Holdings Ltd (ASX:ECS) for AUD 3 million. Oct 24
Full year 2022 earnings released: AU$0.001 loss per share (vs AU$0.006 loss in FY 2021) Sep 02
ECS Botanics Holdings Ltd, Annual General Meeting, Oct 26, 2022 Aug 26
MD & Executive Director recently bought AU$90k worth of stock Jun 29
ECS Botanics Holdings Ltd Announces Change of Managing Director Jun 15
ECS Botanics Holdings Ltd Announces Executive Changes Jun 14
No independent directors Apr 27
Founder exercised options to buy AU$510k worth of stock. Sep 11
Full year 2021 earnings released: AU$0.006 loss per share (vs AU$0.009 loss in FY 2020) Sep 03
ECS Botanics Holdings Ltd Launches Innovative range of 30ml Terpene Blends May 21 ECS Botanics Holdings Ltd Appoints Nan Maree Schoerie as Director
ECS Botanics Holdings (ASX:ECS) Is In A Good Position To Deliver On Growth Plans Feb 24
First half 2021 earnings released: AU$0.005 loss per share (vs AU$0.008 loss in 1H 2020) Feb 24
ECS Botanics Holdings Ltd Appoints Paul Hanrahan as Site & Cultivation Manager Feb 02
ECS Botanics Holdings Ltd (ASX:ECS) signed a binding term sheet to acquire Murray Meds Pty Ltd, Flowerday Farms Pty Ltd and Flowerday Land Property from Flowerday Holdings Pty Ltd for AUD 7.5 million. Jan 13
ECS Botanics Holdings Ltd Enters into Term Sheet with Medipharm Labs Dec 26
ECS Botanics Holdings Ltd announced that it expects to receive AUD 4 million in funding Dec 13
ECS Provides Medicinal Cannabis Project and Regulatory Update Nov 24
ECS Botanics Holdings Ltd Appoints Damian Wood as Director of Medicinal Cannabis Production Oct 29
ECS Botanics Holdings Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.75 million. Aug 18
Financial Position Analysis
Short Term Liabilities: ECS's short term assets (A$19.7M) exceed its short term liabilities (A$3.9M).
Long Term Liabilities: ECS's short term assets (A$19.7M) exceed its long term liabilities (A$785.2K).
Debt to Equity History and Analysis
Debt Level: ECS is debt free.
Reducing Debt: ECS has no debt compared to 5 years ago when its debt to equity ratio was 1.3%.
Debt Coverage: ECS has no debt, therefore it does not need to be covered by operating cash flow .
Interest Coverage: ECS has no debt, therefore coverage of interest payments is not a concern.
Discover healthy companies Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"control","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
